News

Bioniche and Synerx have announced the FDA approval and launch of Melphalan Hydrochloride for Injection, the generic equivalent of Alkeran from GlaxoSmithKline. Bioniche and Synerx entered into an

United Therapeutics and Eli Lilly have announced the results of a pivotal 16-week study. The results showed that once-daily dose of tadalafil was generally well tolerated, improved exercise

BioMarin has declared results from the Phase-I clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), for the treatment of phenylketonuria (PKU). The company expects to initiate the

D-Pharm announced that it has received FDA approval for its Investigational New Drug (IND) application for a pivotal Phase III clinical trial of DP-b99 in acute ischemic stroke

PDX and Rx.com have entered into a strategic agreement with Microsoft to make prescription data, which Rx.com manages for multiple chain and independent pharmacy clients, available to Microsoft

iMedica Corporation, a leading developer of healthcare software solutions for physician practices, announced that after more than two years of research and consideration, the Physicians’ Organization of the

Millipore expects the new facility will employ 120 before the end of 2009. The company currently employs over 1,000 in Massachusetts and almost 6,000 around the world. Millipore’s

The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their

Progenics has announced the discontinuation of the development program for PRO 206, a pre-clinical compound for the treatment of hepatitis-C virus (HCV) infection. The decision was made as